FNY Investment Advisers LLC Acquires Shares of 5,193 Surgery Partners, Inc. $SGRY

FNY Investment Advisers LLC acquired a new stake in Surgery Partners, Inc. (NASDAQ:SGRY) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 5,193 shares of the company’s stock, valued at approximately $115,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in SGRY. Pentwater Capital Management LP raised its holdings in shares of Surgery Partners by 545.2% during the 1st quarter. Pentwater Capital Management LP now owns 2,742,000 shares of the company’s stock worth $65,122,000 after acquiring an additional 2,317,000 shares during the period. TIG Advisors LLC purchased a new position in shares of Surgery Partners during the 1st quarter worth $46,902,000. Wellington Management Group LLP raised its holdings in shares of Surgery Partners by 19.7% during the 1st quarter. Wellington Management Group LLP now owns 7,091,756 shares of the company’s stock worth $168,429,000 after acquiring an additional 1,165,667 shares during the period. Alpine Associates Management Inc. purchased a new position in shares of Surgery Partners during the 1st quarter worth $13,539,000. Finally, Woodline Partners LP purchased a new position in shares of Surgery Partners during the 1st quarter worth $12,478,000.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on SGRY. Weiss Ratings reiterated a “sell (d-)” rating on shares of Surgery Partners in a report on Wednesday, October 8th. Cantor Fitzgerald reiterated an “overweight” rating and set a $36.00 price target on shares of Surgery Partners in a report on Tuesday, October 7th. JPMorgan Chase & Co. began coverage on Surgery Partners in a report on Thursday, September 18th. They set a “neutral” rating and a $27.00 price target on the stock. Finally, Bank of America began coverage on Surgery Partners in a report on Monday, July 28th. They set a “buy” rating and a $28.00 price target on the stock. Five analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $31.14.

Surgery Partners Stock Up 3.2%

Shares of NASDAQ:SGRY opened at $21.97 on Friday. The business has a 50-day moving average price of $21.79 and a 200 day moving average price of $22.06. The company has a current ratio of 1.93, a quick ratio of 1.78 and a debt-to-equity ratio of 1.10. The company has a market capitalization of $2.82 billion, a price-to-earnings ratio of -15.36 and a beta of 1.83. Surgery Partners, Inc. has a 12-month low of $18.87 and a 12-month high of $31.98.

Surgery Partners (NASDAQ:SGRY) last issued its quarterly earnings data on Tuesday, August 5th. The company reported $0.17 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.16 by $0.01. The firm had revenue of $826.20 million during the quarter, compared to the consensus estimate of $816.96 million. Surgery Partners had a positive return on equity of 2.51% and a negative net margin of 5.57%.The company’s quarterly revenue was up 8.4% on a year-over-year basis. During the same period last year, the company earned $0.21 EPS. Sell-side analysts expect that Surgery Partners, Inc. will post 0.67 EPS for the current year.

Insider Transactions at Surgery Partners

In related news, Director Teresa Deluca sold 20,018 shares of the firm’s stock in a transaction dated Monday, August 11th. The stock was sold at an average price of $22.74, for a total transaction of $455,209.32. Following the completion of the sale, the director directly owned 45,173 shares of the company’s stock, valued at approximately $1,027,234.02. This trade represents a 30.71% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Harrison R. Bane sold 9,339 shares of Surgery Partners stock in a transaction dated Thursday, September 4th. The shares were sold at an average price of $22.48, for a total value of $209,940.72. Following the completion of the transaction, the insider directly owned 117,181 shares of the company’s stock, valued at approximately $2,634,228.88. This represents a 7.38% decrease in their ownership of the stock. The disclosure for this sale can be found here. 2.70% of the stock is currently owned by company insiders.

Surgery Partners Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.